Becton Dickinson said on Wednesday its board has authorized a plan to separate its life sciences unit as the medical device maker aims to focus on its core business.
The company has been restructuring its business portfolio in recent years, having previously divested its diabetes care and surgical instrumentation unit.
Becton's life sciences division makes diagnostic products such as those used to detect infectious diseases and cancers.
Earlier this week, the Financial Times reported activist investor Starboard Value had taken a stake in Becton and was pushing the company to sell its life sciences unit.
https://ca.finance.yahoo.com/news/becton-dickinson-looks-separate-life-215215171.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.